Laurent et al. provide evidence that immune checkpoint pathways, including PD-L1, are upregulated in EBV+ PBL, though the most prominent expression is on microenvironmental (not necessarily neoplastic) cells; explicit tumor cell PD-L1 positivity is relatively less common [68]. Here, CD274 is linked to neoplasm.